Direkt zum Inhalt

Our Mission

Support and drive the adoption of
human genetic diagnostics into clinical practice

Our focus

Process steps which are facing the unmet need
in genetic diagnostics

Our offer

Innovative IT solutions supporting genetic labs
in translating genetic test results into clinical recommendations

bio.logis GIMS - Home of the Clinical Interpretome

News

| Artikel
Personalisierte Medizin in Hessen - Unternehmensporträt bio.logis

Die Broschüre "Personalisierte Medizin in Hessen" ist als aktualisierte Neuauflage erschienen. Lesen Sie darin ein Unternehmensporträt zu bio.logis GIM. Hier gehts zum Download der Broschüre, herausgegeben von Hessen Trade & Invest GmbH.

Weiterlesen über Personalisierte Medizin in Hessen - Unternehmensporträt bio.logis > alle News >

Events

| Konferenz
Meet bio.logis at DELAB and 5th German PharmTox Summit

bio.logis will take part in both meetings and our team looks forward to exchanging ideas with you. At the 5th German PharmTox summit we will have a presentation on GIMS.pharma as part of the "Meet the Company" session.

Weiterlesen über Meet bio.logis at DELAB and 5th German PharmTox Summit > alle Events >

 

 

Get in touch and discover what GIMS can do for your lab!

request a demo >

GIMS Modules

Knowledge Management Module

Structured documentation of genetic knowledge

more >

Diagnostic Report Module

Efficient production of diagnostic reports

more >

Icon Delivery Module

Delivery Module
 

Digital delivery and presentation of results

more >

Testimonials

„We are convinced, that the Diagnostic Report Module of the bio.logis Genetic Information Management Suite will improve the process of creating more valuable results, which we provide to our clients (i.e. physicians). This will help us to build a competition advantage.“

Dr. med. Michal Milczarek, Director Operations, Alab Laboratories, Poland

"bio.logis is the ideal partner for us to implement personalized pharmacogenetic diagnostics.
We know the GIM system from the EU project Ubiquitious Pharmacogenomics, in which it has already proven its efficiency."

Prof. Dr. Matthias Schwab, Head of Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart
U-PGX logo short

Participation in EU-Projects within Horizon 2020 program

  • Ubiquitous Pharmacogenomics (U-PGx)
  • Genetics Clinic of the Future (GCOF)

more >